BBIO - BridgeBio Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BBIO is currently covered by 12 analysts with an average price target of $45.29. This is a potential upside of $18.69 (70.26%) from yesterday's end of day stock price of $26.6.

BridgeBio Pharma's activity chart (see below) currently has 81 price targets and 109 ratings on display. The stock rating distribution of BBIO is 98.25% BUY and 1.75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.04% with an average time for these price targets to be met of 223.5 days.

Highest price target for BBIO is $70, Lowest price target is $43, average price target is $45.29.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 25-Nov-2024. First documented stock forecast 22-Jul-2019.

Currently out of the existing stock ratings of BBIO, 56 are a BUY (98.25%), 1 are a HOLD (1.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$49

$21.91 (80.88%)

$43

8 days ago
(25-Nov-2024)

6/25 (24%)

$19.21 (64.48%)

327

Buy

$45

$17.91 (66.11%)

$42

8 days ago
(25-Nov-2024)

2/6 (33.33%)

$15.21 (51.06%)

46

Buy

$45

$17.91 (66.11%)

$44

18 days ago
(15-Nov-2024)

3/5 (60%)

$21.99 (95.57%)

220

Buy

$46

$18.91 (69.80%)

$48

1 months 16 days ago
(17-Oct-2024)

12/17 (70.59%)

$19.81 (75.64%)

294

Buy

$70

$42.91 (158.40%)

$70

2 months 17 days ago
(16-Sep-2024)

1/8 (12.5%)

$43.81 (167.28%)

244

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BBIO (BridgeBio Pharma) average time for price targets to be met?

On average it took 223.5 days on average for the stock forecasts to be realized with a an average price target met ratio 60.04

Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?

TYLER VAN BUREN

Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?

Tyler Van Buren works at TD COWEN and has 5 price targets and 3 ratings on BBIO

Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?

Josh Schimmer with highest potential upside - $42.91

Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?

Thomas Shrader with lowest potential downside - -$3.73

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?